B-cell non-Hodgkin lymphoma

Caribou Scores Early CAR-T Lymphoma Win, Plans $125M Public Offering
BioSpace
Fri, 07/14/23 - 10:03 am
Caribou Biosciences
CAR-T
CB-010
B-cell non-Hodgkin lymphoma
cell therapy
Adicet soars on early responses to gamma delta CAR-T therapy
Fierce Biotech
Mon, 12/6/21 - 10:49 am
Adicet Bio
CAR-T
cell therapy
ADI-001
clinical trials
B-cell non-Hodgkin lymphoma
JPM: Regeneron has spoken with the FDA about odronextamab hold, hopes to get patients back soon
Fierce Biotech
Mon, 01/11/21 - 10:29 am
Regeneron
FDA
odronextamab
clinical hold
B-cell non-Hodgkin lymphoma
Regeneron's blood cancer hopeful odronextamab hit with FDA partial hold across several trials
Fierce Biotech
Tue, 12/15/20 - 10:49 am
Regeneron
FDA
clinical trials
odronextamab
B-cell non-Hodgkin lymphoma
Unum racks up yet another FDA hold as it twists its way through a restructuring, looking for a fresh start with a preclinical drug
Endpoints
Mon, 03/9/20 - 11:36 pm
Unum Therapeutics
ACTR707
B-cell non-Hodgkin lymphoma
clinical trials
Years in the unmaking, CTI’s Pixuvri fails a pivotal PhIII combo study for lymphoma — can it remain on the market?
Endpoints
Mon, 07/9/18 - 12:00 pm
CTI Pharma
Pixuvri
B-cell non-Hodgkin lymphoma
clinical trials
ASCO18: Celgene makes its case as CAR-T rival in lymphoma
Biopharma Dive
Mon, 06/4/18 - 09:34 am
Celgene
JCAR017
liso-cel
CAR-T
B-cell non-Hodgkin lymphoma
ASCO 2018